Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 23,018 | 17,596 | 15,517 | 11,457 | 9,740 |
| Operating Income | -23,018 | -17,596 | -15,517 | -11,457 | -9,740 |
| Other Income | 1,328 | 1,276 | 1,240 | 1,357 | 1,061 |
| Pre-tax Income | -21,690 | -16,320 | -14,277 | -10,100 | -8,679 |
| Net Income Continuous | -21,690 | -16,320 | -14,277 | -10,100 | -8,679 |
| Net Income | $-21,690 | $-16,320 | $-14,277 | $-10,100 | $-8,679 |
| EPS Basic Total Ops | -0.65 | -0.50 | -0.45 | -0.32 | -0.28 |
| EPS Basic Continuous Ops | -0.65 | -0.50 | -0.45 | -0.32 | -0.28 |
| EPS Diluted Total Ops | -0.65 | -0.50 | -0.45 | -0.32 | -0.28 |
| EPS Diluted Continuous Ops | -0.65 | -0.50 | -0.45 | -0.32 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.50 | -0.45 | -0.32 | -0.28 |
| EBITDA(a) | $-23,018 | $-17,596 | $-15,517 | $-11,339 | $-9,740 |